1545-0013 Screening compound: 6-methyl-5-(morpholin-4-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione

1545-0013 Screening compound: 6-methyl-5-(morpholin-4-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione
1545-0013 Screening compound: 6-methyl-5-(morpholin-4-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound 1545-0013
6-methyl-5-(morpholin-4-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

1545-0013

Molecular Formula

C9H13N3O3 (C9 H13 N3 O3)

Compound Name

6-methyl-5-(morpholin-4-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione

IUPAC name

6-methyl-5-(morpholin-4-yl)-1234-tetrahydropyrimidine-24-dione

SMILES

CC(NC(NC1=O)=O)=C1N1CCOCC1

InChI

InChI=1S/C9H13N3O3/c1-6-7(8(13)11-9(14)10-6)12-2-4-15-5-3-12/h2-5H2,1H3,(H2,10,11,13,14)

InChI Key

ZYJVCZIRSBFPCJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00233547

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

211.22

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

1.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

-0.208

Distribution Coefficient, logD

-2.025

Water Solubility, LogSw

-1.34

Polar Surface Area

60.052

Acid Dissociation Constant (pKa)

5.59

Base Dissociation Constant (pKb)

4.86

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

55.60

1545-0013 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Dark Chemical Matter Library (18430 compounds)

Fragments Library (11262 compounds)

Nucleoside Mimetics Library (2197 compounds)

Akt-Targeted Library (14764 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Pool
  • Fragments
  • Mimetics
Therapeutical areas:
  • Antiviral
  • Infections
  • Cancer
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with 1545-0013 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 1545-0013?
Check Price and Availability of 1545-0013, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 1545-0013 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 1545-0013
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 1545-0013
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 1545-0013 available by request